Voltron Therapeutics, Inc., a Lucius Partners Portfolio Comp

/PRNewswire/ -- Voltron Therapeutics, a Lucius Partners portfolio company, presented new evidence that demonstrates its VaxCelerate Vaccine platform's...

Related Keywords

Orlando , Florida , United States , Massachusetts , Delaware , Patrick Gallagher , Voltron Vaxcelerate , Mark Poznansky , James Ahern , Immunotherapy Center , Exchange Commission , Lucius Partners , Immunotherapy Center At Massachusetts , Presentation At Military Health System Research Symposium , Voltron Therapeutics Inc , Department Of Defense Do , Health System Research Symposium , Papilloma Virus , Military Health System Research Symposium , Voltron Therapeutics , Vaxcelerate Vaccine , Massachusetts General , Lassa Fever , Novel Self Assembling Vaccine , Inhibits Tumor Growth , Tumor Model , Neck Cancer , Massachusetts General Hospital , Voltron Therapeutic , Self Assembling Vaccine , Emerging Infectious , Private Securities Litigation Reform Act , Vaxcelerate Platform ,